These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 21965338)

  • 81. Precision treatment exploration of breast cancer based on heterogeneity analysis of lncRNAs at the single-cell level.
    Zhang Y; Zhang D; Meng Q; Liu Z; Xie H; Liu L; Xu F; Chen X
    BMC Cancer; 2021 Aug; 21(1):918. PubMed ID: 34388989
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen.
    Jansen MP; Martens JW; Helmijr JC; Beaufort CM; van Marion R; Krol NM; Monkhorst K; Trapman-Jansen AM; Meijer-van Gelder ME; Weerts MJ; Ramirez-Ardila DE; Dubbink HJ; Foekens JA; Sleijfer S; Berns EM
    Oncotarget; 2016 Jul; 7(28):43412-43418. PubMed ID: 27270325
    [TBL] [Abstract][Full Text] [Related]  

  • 83. ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer.
    Kalyuga M; Gallego-Ortega D; Lee HJ; Roden DL; Cowley MJ; Caldon CE; Stone A; Allerdice SL; Valdes-Mora F; Launchbury R; Statham AL; Armstrong N; Alles MC; Young A; Egger A; Au W; Piggin CL; Evans CJ; Ledger A; Brummer T; Oakes SR; Kaplan W; Gee JM; Nicholson RI; Sutherland RL; Swarbrick A; Naylor MJ; Clark SJ; Carroll JS; Ormandy CJ
    PLoS Biol; 2012; 10(12):e1001461. PubMed ID: 23300383
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA.
    Korshunova Y; Maloney RK; Lakey N; Citek RW; Bacher B; Budiman A; Ordway JM; McCombie WR; Leon J; Jeddeloh JA; McPherson JD
    Genome Res; 2008 Jan; 18(1):19-29. PubMed ID: 18032725
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study.
    Yi Z; Ma F; Liu B; Guan X; Li L; Li C; Qian H; Xu B
    BMC Cancer; 2019 May; 19(1):442. PubMed ID: 31088410
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer.
    D'Oronzo S; Lovero D; Palmirotta R; Stucci LS; Tucci M; Felici C; Cascardi E; Giardina C; Cafforio P; Silvestris F
    Sci Rep; 2019 Nov; 9(1):17276. PubMed ID: 31754145
    [TBL] [Abstract][Full Text] [Related]  

  • 87. miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer.
    Zubor P; Kubatka P; Dankova Z; Gondova A; Kajo K; Hatok J; Samec M; Jagelkova M; Krivus S; Holubekova V; Bujnak J; Laucekova Z; Zelinova K; Stastny I; Nachajova M; Danko J; Golubnitschaja O
    Future Oncol; 2018 Aug; 14(18):1847-1867. PubMed ID: 30019928
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping.
    Zugazagoitia J; Ramos I; Trigo JM; Palka M; Gómez-Rueda A; Jantus-Lewintre E; Camps C; Isla D; Iranzo P; Ponce-Aix S; García-Campelo R; Provencio M; Franco F; Bernabé R; Juan-Vidal O; Felip E; de Castro J; Sanchez-Torres JM; Faul I; Lanman RB; Garrido P; Paz-Ares L
    Ann Oncol; 2019 Feb; 30(2):290-296. PubMed ID: 30535340
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model.
    Maguire SL; Peck B; Wai PT; Campbell J; Barker H; Gulati A; Daley F; Vyse S; Huang P; Lord CJ; Farnie G; Brennan K; Natrajan R
    J Pathol; 2016 Nov; 240(3):315-328. PubMed ID: 27512948
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
    Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
    Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Molecular classification of breast tumors: toward improved diagnostics and treatments.
    Sørlie T
    Methods Mol Biol; 2007; 360():91-114. PubMed ID: 17172726
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The emerging role of the molecular diagnostics laboratory in breast cancer personalized medicine.
    De Abreu FB; Wells WA; Tsongalis GJ
    Am J Pathol; 2013 Oct; 183(4):1075-1083. PubMed ID: 23920325
    [TBL] [Abstract][Full Text] [Related]  

  • 94. What are we learning from the cancer genome?
    Collisson EA; Cho RJ; Gray JW
    Nat Rev Clin Oncol; 2012 Nov; 9(11):621-30. PubMed ID: 22965149
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cancer detection using whole-genome sequencing of cell free DNA.
    Leary RJ; Sausen M; Diaz LA; Velculescu VE
    Oncotarget; 2013 Aug; 4(8):1119-20. PubMed ID: 23912395
    [No Abstract]   [Full Text] [Related]  

  • 96. Breast cancer genome heterogeneity: a challenge to personalised medicine?
    Swanton C; Burrell RA; Futreal PA
    Breast Cancer Res; 2011 Feb; 13(1):104. PubMed ID: 21345264
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Unique molecular landscapes in cancer: implications for individualized, curated drug combinations.
    Wheler J; Lee JJ; Kurzrock R
    Cancer Res; 2014 Dec; 74(24):7181-4. PubMed ID: 25326492
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Heterogeneity in breast cancer.
    Polyak K
    J Clin Invest; 2011 Oct; 121(10):3786-8. PubMed ID: 21965334
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The impact of whole-genome sequencing on the reconstruction of human population history.
    Veeramah KR; Hammer MF
    Nat Rev Genet; 2014 Mar; 15(3):149-62. PubMed ID: 24492235
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Predictive and prognostic factors.
    Dowsett M
    Breast Cancer Res; 2010 Dec; 12 Suppl 4(Suppl 4):S2. PubMed ID: 21172082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.